The Journal of Community and Supportive OncologyProviding Pain and Palliative Care Education Internationally July 2, 2011
The Journal of Community and Supportive OncologyA randomized phase III trial of BIBW 2992 versus chemotherapy as first-line treatment for stage IIIB/IV adenocarcinoma of the lung harboring an epidermal growth factor receptor-activating mutationJuly 1, 2010
Oncology PracticeFarletuzumab (MORAb-003) in platinum-sensitive ovarian cancer patients experiencing a first relapseApril 1, 2010Gynecologic Cancer
